Royalty Pharma plc
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $7.27B | $17.52B | $1.54B |
| FY2022 | $7.29B | $16.81B | $1.71B |
| FY2023 | $6.30B | $16.38B | $477.0M |
| FY2024 | $7.88B | $18.22B | $929.0M |
| FY2025 | $9.91B | $19.62B | $618.7M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $7.27B | $17.52B | $1.54B |
| FY2022 | $7.29B | $16.81B | $1.71B |
| FY2023 | $6.30B | $16.38B | $477.0M |
| FY2024 | $7.88B | $18.22B | $929.0M |
| FY2025 | $9.91B | $19.62B | $618.7M |